Structured evidence table for Maca Menopause Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Maca Menopause Randomized Trial | This study aims to use a network meta-analysis (NMA) to compare the effectiveness and safety of various dietary supplements based on outcomes such as hair density and terminal hair density, providing evidence-based support for clinical decision-making. | 1 | Zhou L (2026) | Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis. |
| Maca Menopause Randomized Trial | Stata 16.0 software was used for network meta-analysis, and Revman 5.4 software was utilized for evaluating study quality and bias risk; additionally, the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework was applied to rate the certainty (quality) of evidence for the included studies. | 1 | Zhou L (2026) | Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis. |
| Maca Menopause Randomized Trial | Results showed that compared with placebo, standardized plant extracts (Nutrafol), apple extract (AMSbzs, AMS), tocotrienols, pumpkin seed oil (PSO), and a compound extract of Cistanche and Laminaria (MK-R7) significantly improved hair density. | 1 | Zhou L (2026) | Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis. |
| Maca Menopause Randomized Trial | Background In recent years, androgenetic alopecia (AGA) has emerged as a significant public health concern due to its high prevalence and progressive nature. | 1 | Zhou L (2026) | Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis. |
| Maca Menopause Randomized Trial | Background: Middle-aged women frequently experience diverse physical and psychological symptoms, including depression, anxiety, sleep disturbances, vasomotor symptoms, and reduced quality of life, during menopause. | 1 | Kim JH (2025) | Nonpharmacological Intervention Effects on Middle-Aged Women with Menopausal Symptoms: A Systematic Review and Meta-Analysis. |
| Maca Menopause Randomized Trial | Risk of bias was assessed using the Cochrane risk of bias tool, and meta-analyses were performed using a random effects model. | 1 | Kim JH (2025) | Nonpharmacological Intervention Effects on Middle-Aged Women with Menopausal Symptoms: A Systematic Review and Meta-Analysis. |
| Maca Menopause Randomized Trial | Results: Nonpharmacological interventions significantly reduced symptoms of depression (standardized mean difference (SMD) = -1.10), anxiety (-0.82), sleep disturbances (-0.90), menopausal symptoms (-1.18), and hot flashes (-0.34). | 1 | Kim JH (2025) | Nonpharmacological Intervention Effects on Middle-Aged Women with Menopausal Symptoms: A Systematic Review and Meta-Analysis. |
| Maca Menopause Randomized Trial | With increasing concerns regarding the side effects of hormone therapy, nonpharmacological interventions have emerged as safer alternatives for symptom management. | 1 | Kim JH (2025) | Nonpharmacological Intervention Effects on Middle-Aged Women with Menopausal Symptoms: A Systematic Review and Meta-Analysis. |
Source documents